disCase vs Rssdi India
Price, ratings, monetisation and update history for both apps, side by side ā with what reviewers say about each.
disCase
Read full descriptionHide full description
disCase app is created to Educate, Empower, and Engage doctors in clinical practice Description: Continuing the efforts to improve the standard of diabetes care in World, disCase app is a trusted and reliable source to help clinical practitioner in their clinical practice. disCase app trusted content was developed with healthcare professionals (HCP) in mind and provide streamlined functionality and access to Continuing Medical Education (CME) content. The module contents are endorsed by Reputed Medical schools across globe. App features: ⢠Streamlined functionality and easy navigation to each of the content repository ⢠Access to modules ⢠Case study content with schedule option for group and one to one discussion with subject expert. ⢠Persistent login, so you need to log into the app only once ⢠Interactive quizzes and polls ⢠Insulin Initiation Kit ⢠Resources ⢠Chatbot
Rssdi India
Read full descriptionHide full description
Welcome to the official app of the Research Society for the Study of Diabetes in India (RSSDI), a premier organization dedicated to advancing diabetes research, education, and care in India. Founded in 1972 by Prof. M.M.S. Ahuja, RSSDI has grown to represent life members from 21 Indian states and union territories. Our mission is to promote cutting-edge research, improve clinical practice, and enhance the prevention and management of diabetes. This app provides exclusive access to: - Organization updates and news - Committee and management information - Grants and funding opportunities - Accreditation centers and programs - Upcoming events and conferences - Photo gallery and archives Stay connected with RSSDI and stay updated on the latest developments in diabetes research and care. Disclaimer: Rssdi India app is developed only for educational purpose. It is purely intended to promote awareness and knowledge regarding Diabetes Rssdi India does not undertake any medico legal responsibility, arising from use of these skills, on user's behalf.
Screenshots
Verdict
The clearest difference is update cadence: Rssdi India at every 11 days against disCase's every 10 months. Rssdi India also leads on iOS requirement (12.0 vs 14.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price Ā· Rating Ā· Positive reviews Ā· Number of ratings Ā· Update frequency Ā· Ads Ā· In-app purchases Ā· Monetization Ā· Best chart rank Ā· Devices Ā· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
disCase ships an update every 10 months, Rssdi India every 11 days. The most recent releases landed on October 9, 2026 and October 6, 2026 respectively.
| Parameter | disCase | Rssdi India |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 10 months | Every 11 days ā better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod ā better | iPhone, iPod |
| Requires iOS | 14.0 | 12.0 ā better |
| Further details ā not scored | ||
| Size | 194 MB | 44 MB |
| Age rating | 17+ | 17+ |
| Developer | Sanofi Winthrop Industrie | Research Society for the Study of Diabetes in India - RSSDI |
In-app purchases
disCase
No in-app purchases
Rssdi India
No in-app purchases









